← All trials
NCT02323100
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2017
- Primary completion
- Jun 1, 2019
- Completion date
- Apr 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 36
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of Colorado, DenverLead sponsor
- University of Colorado, DenverOverall official - principal investigator
- University of Colorado, DenverReponsible party - principal investigator
- Johns Hopkins UniversityCollaborator
- University of PennsylvaniaCollaborator
- University of Alabama, BirminghamCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.